BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8868401)

  • 1. Fluorometric HPLC determination of delta-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure.
    Oishi H; Nomiyama H; Nomiyama K; Tomokuni K
    J Anal Toxicol; 1996; 20(2):106-10. PubMed ID: 8868401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of colorimetric and HPLC methods for determination of delta-aminolevulinic acid in urine with reference to dose-response relationship in occupational exposure to lead.
    Fukui Y; Miki M; Ukai H; Okamoto S; Takada S; Ikeda M
    Ind Health; 2005 Oct; 43(4):691-8. PubMed ID: 16294925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: a sensitive indicator of lead effects.
    Morita Y; Araki S; Sakai T; Araki T; Masuyama Y
    Ind Health; 1994; 32(2):85-96. PubMed ID: 7806449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of urinary delta-aminolevulinic acid (ALA) by fluorometric HPLC and colorimetric methods.
    Tomokuni K; Ichiba M; Hirai Y
    Ind Health; 1992; 30(3-4):119-28. PubMed ID: 1301411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized liquid-chromatographic method for fluorometric determination of urinary delta-aminolevulinic acid in workers exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y; Hasegawa T
    Clin Chem; 1987 Sep; 33(9):1665-7. PubMed ID: 3621570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the fluorometric HPLC method and the conventional method for determining urinary delta-aminolevulinic acid and coproporphyrin as indices of lead exposure.
    Tomokuni K; Ichiba M; Hirai Y; Sugimoto K; Yoshida T; Hirata M
    Int Arch Occup Environ Health; 1988; 61(3):153-6. PubMed ID: 3220586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelation between urinary delta-aminolevulinic acid (ALA), serum ALA, and blood lead in workers exposed to lead.
    Tomokuni K; Ichiba M; Fujishiro K
    Ind Health; 1993; 31(2):51-7. PubMed ID: 8226113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between males and females with respect to the porphyrin metabolic disorders found in workers occupationally exposed to lead.
    Oishi H; Nomiyama H; Nomiyama K; Tomokuni K
    Int Arch Occup Environ Health; 1996; 68(5):298-304. PubMed ID: 8832294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the evaluation of exposure to industrial chemicals].
    Sakai T
    Sangyo Eiseigaku Zasshi; 1996 May; 38(3):119-37. PubMed ID: 8689499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical dose of lead affecting delta-aminolevulinic acid levels.
    Murata K; Sakai T; Morita Y; Iwata T; Dakeishi M
    J Occup Health; 2003 Jul; 45(4):209-14. PubMed ID: 14646278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between plasma 5-aminolevulinic acid concentrations and indicators of oxidative stress in lead-exposed workers.
    Costa CA; Trivelato GC; Pinto AM; Bechara EJ
    Clin Chem; 1997 Jul; 43(7):1196-202. PubMed ID: 9216456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between urinary beta-aminoisobutyric acid excretion and concentration of lead in the blood of workers occupationally exposed to lead.
    Tomokuni K; Ichiba M; Mori K
    Br J Ind Med; 1992 May; 49(5):365-8. PubMed ID: 1599874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between lead in plasma and other indicators of lead exposure among lead-exposed workers.
    Hirata M; Yoshida T; Miyajima K; Kosaka H; Tabuchi T
    Int Arch Occup Environ Health; 1995; 68(1):58-63. PubMed ID: 8847114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorometric measurement of 5-aminolevulinic acid in serum.
    Lee C; Qiao X; Goeger DE; Anderson KE
    Clin Chim Acta; 2004 Sep; 347(1-2):183-8. PubMed ID: 15313157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delta-Aminolevulinic acid in urine (screening method)].
    Tomokuni K
    Nihon Rinsho; 1995 Jun; 53(6):1383-8. PubMed ID: 7616651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct injection method for quantitation of delta-aminolevulinic acid in urine by high-performance liquid chromatography.
    Kondo M; Kimura H; Maekubo T; Tomita T; Senda M; Urata G; Kajiwara M
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1948-50. PubMed ID: 1394716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of delta-aminolaevulinic acid in blood of workers exposed to lead.
    Takebayashi T; Omae K; Hosoda K; Satoh T; Hamaguchi T; Sakurai H
    Br J Ind Med; 1993 Jan; 50(1):49-54. PubMed ID: 8431390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized fluorometric determination of urinary delta-aminolevulinic acid by using pre-column derivatization, and identification of the derivative.
    Okayama A; Fujii S; Miura R
    Clin Chem; 1990 Aug; 36(8 Pt 1):1494-7. PubMed ID: 2103726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. delta-Aminolevulinic acid in plasma or whole blood as a sensitive indicator of lead effects, and its relation to the other heme-related parameters.
    Sakai T; Morita Y
    Int Arch Occup Environ Health; 1996; 68(2):126-32. PubMed ID: 8720283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of urinary delta-aminolevulinic acid determination by HPLC and fluorescence detection using condensing reaction with acetylacetone and formaldehyde.
    Endo Y; Okayama A; Endo G; Ueda T; Nakazono N; Horiguchi S
    Sangyo Igaku; 1994 Mar; 36(2):49-56. PubMed ID: 8007435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.